Pune, Maharashtra, India, September 20 2022 (Wiredrelease) Prudour Pvt. Ltd –:Global Veno-Venous ECMO System Market: IntroductionThe Veno-Venous ECMO system is a new medical device that promises to ...

P hilips’ Duo Venous stent system has been implanted into the first patient with symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), outside a clinical trial.

Of patients with chronic limb-threatening ischemia and no revascularization options, 76% avoided amputation after a procedure that delivers oxygenated blood to an ischemic foot via the venous system.

DelveInsight's Chronic Venous Insufficiency Market Insights report includes a comprehensive understanding of current treatment practices, chronic venous insufficiency emerging drugs/devices ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the first implant of the Duo Venous Stent System, an implantable medical device indicated to treat ...

The system can treat patients with CLTI who cannot have revascularization. LimFlow announced that its transcatheter deep venous arterialization system for treatment of chronic limb-threatening ...

Chronic venous insufficiency arises from a complex interplay of genetic predisposition; environmental factors, such as jobs that require prolonged standing or carrying heavy loads; and age-related ...